Milestone Scientific Begins CompuFlo® Epidural System Sales at The Painless Center

Innovative pressure-sensing technology now in use at leading New Jersey pain management clinic, enhancing safety and precision in epidural procedures

Milestone Scientific has marked another commercial milestone with the introduction of its CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey. Led by Dr. Chi-Shin Jason Chiu—a double board-certified expert in Pain Management and Anesthesiology—the center is among the first to adopt the innovative system that offers real-time, objective feedback during epidural procedures. This rollout reflects growing clinical confidence in CompuFlo’s ability to enhance procedural precision and reduce complications associated with traditional techniques.

The CompuFlo Epidural System is powered by Milestone Scientific’s proprietary Dynamic Pressure Sensing® (DPS) technology, which allows clinicians to accurately identify the epidural space with immediate feedback. This dramatically reduces the risk of false loss of resistance, improves first-attempt success rates, and heightens patient safety and comfort. Dr. Chiu emphasized the technology's alignment with The Painless Center’s mission to integrate advanced tools that optimize patient outcomes and procedural efficacy.

As part of a broader commercialization strategy, Milestone Scientific continues expanding its footprint in interventional pain management across the U.S. and globally. With proven clinical benefits and growing endorsements from leading specialists, the CompuFlo system is well-positioned to redefine standards in epidural administration. The deployment at The Painless Center underscores the device’s potential to transform routine pain interventions into safer, more predictable procedures backed by real-time analytics.


MedTech Spectrum's Summary

Enhanced Procedural Safety: Milestone Scientific’s CompuFlo® Epidural System leverages Dynamic Pressure Sensing® (DPS) technology to provide real-time feedback, significantly improving the accuracy and safety of epidural injections.

Clinical Endorsement and Adoption: The system’s commercial launch at The Painless Center under the leadership of Dr. Chi-Shin Jason Chiu reflects growing trust in its ability to reduce complications and enhance patient outcomes in interventional pain management.

Strategic Growth Outlook: With successful deployments in leading institutions and strong clinical backing, CompuFlo is positioned to drive a new standard in epidural care and accelerate adoption across the U.S. and international markets.